ReviewJournal of the Society for Cardiovascular Angiography & Interventions
The Current Landscape of Transcatheter Tricuspid Valve Intervention.
Review in Journal of the Society for Cardiovascular Angiography & Interventions. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed.
- Incremental Prognostic Value of Wearable-Derived Heart Rate and Activity Circadian Features in Tricuspid Regurgitation.JACC. Advances · 2026Article
- Outcomes after tricuspid transcatheter edge-to-edge repair: a systematic review and meta-analysis.Annals of cardiothoracic surgery · 2026Article
- Clinical outcomes of tricuspid transcatheter edge-to-edge repair in patients with tricuspid regurgitation.Frontiers in medicine · 2026Article
- Tricuspid Valve in Congenital Heart Disease Patients: A Triad of Problems and No Remedy in Sight.Journal of the Society for Cardiovascular Angiography & Interventions · 2025Article
- Transcatheter Tricuspid Valve Interventions to Manage Tricuspid Regurgitation: A Narrative Review.Reviews in cardiovascular medicine · 2025Review
- Cardiac implantable electronic devices in the setting of tricuspid valve intervention: Risks, options, extraction and future perspectives: A state-of-the-art review.Heart rhythm O2 · 2025Review
- Long-Term Outcomes of Surgical and Transcatheter Interventions for Tricuspid Regurgitation: A Comprehensive Review.Journal of clinical medicine · 2025Review
- Tricuspid annuloplasty: a piece of the puzzle or the whole picture?EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology · 2025Article
- Caval Transcatheter Valve Implantation: An Alternate Transcatheter Approach to the Treatment of Severe Tricuspid Regurgitation.CASE (Philadelphia, Pa.) · 2025Article
- A dual-chamber leadless pacemaker implantation across percutaneous tricuspid valve-in-valve prosthesis in a patient with Ebstein anomaly.HeartRhythm case reports · 2025Article
- Transcatheter tricuspid valve replacement: will it prevail?Frontiers in cardiovascular medicine · 2025Review
- Transcatheter Management of Tricuspid Regurgitation: A Review of Contemporary Evidence.Heart international · 2024Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Tricuspid regurgitation (TR) is common, and its prevalence increases with age. It was previously estimated that there are 1.6 million patients in the United States with moderate or worse TR, and more contemporary data suggest the age-adjusted prevalence of TR is 0.55%. Increasing TR severity is associated with an adverse prognosis independent of the pulmonary artery pressure and the degree of right heart failure. In heart failure with reduced ejection fraction, survival is significantly worsened when moderate or severe TR is present. The mainstay of therapy has traditionally been surgery, but outcomes are poor. There has been increasing attention on the potential role of transcatheter interventions for TR. Numerous platforms are in developmental evolution, which broadly fall into 3 categories: valve replacement, valve repair (subdivided into annular, leaflet, and chordal platforms), and caval valve implantation. In this review, we examine all these strategies and devices, including guidance on how to appropriately select patients who can benefit from intervention.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.